top of page
Image-empty-state_edited.jpg

TrippBio, Inc.

TrippBio, Inc. Stock 1
TrippBio is developing a new, therapeutic application of an FDA-approved drug with a high probability to be proven safe and efficacious in the treatment and prevention of the SARS-CoV-2 virus that causes COVID-19.

?/100

Crowd Score

Click to request a score

There is a newer open investment round for this company - click here to view
Our take:
​

Thanks, catch you soon!

Sign up to receive weekly deal alerts and top news

Round Performance

Amount Raised

[]

Average-Investment-Icon-p-1600.png
Average Investment

[]

Average-Daily-Investment-Icon-p-1600.png
Average Per Day

[]

Investors-Icon-p-1600.png
# of Investors

[]

Investors vs. Capital Raised

Investment Type

Common Stock

Round Valuation

$5,255,840

Minimum Investment

$100

Price Per Share

$4

​

​

Investment Details

Early Bird Perks

Perk description
Perk level (dollars)
Perk level (days)
Loading...

No early bird perks for this round!

Screen Shot 2020-07-15 at 12.01.28 PM.pn

View early bird perks, company financials, valuation methods, and more

Similar Investments

Image-empty-state_edited.jpg
Phoenix PharmaLabs Inc
Common Stock

© 2023 Crowdonomics

  • Black Facebook Icon
  • Black Twitter Icon
  • Instagram
Privacy Policy
Terms
Contact us

Proudly made in Cincinnati, Ohio

Crowdonomics is not a registered broker-dealer or investment adviser. The investments identified on the Crowdonomics website may not be purchased through Crowdonomics; rather, all transactions will be directly between you and the third-party platform hosting the applicable investment. The information contained herein regarding available investments is obtained from third party sources. While Crowdonomics generally considers such sources to be reliable, Crowdonomics does not represent that such information is accurate or complete, and Crowdonomics has not undertaken any independent review of all information and provides it on an as-is basis.

bottom of page